Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - other biologic treatment
SAT0252 Disease Activity at 3 Month Predicts the Clinical Response at 1 Year Treated by TOCILIZUMAB in Patients with Active Rheumatoid Arthritis: Results from Observational Investigation of Daily Clinical Practice
Compose a Response to This Article
Other responses
No responses have been published for this article.